Average Co-Inventor Count = 4.48
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Human Genome Sciences, Inc. (54 from 676 patents)
2. Combimab, Inc. (1 from 1 patent)
55 patents:
1. 8748575 - Therapeutic peptides
2. 8303951 - Neutrokine-alpha antibodies and methods of use thereof
3. 8231873 - Methods of treatment using antibodies to Neutrokine-alpha
4. 8212004 - Neutrokine-alpha fusion proteins
5. 8173122 - Methods of treatment using antibodies to neutrokine-alpha
6. 8071092 - Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha
7. 8003386 - Tumor necrosis factor receptors 6α and 6β
8. 7994284 - Connective tissue growth factor (CTGF-3) polypeptides
9. 7964190 - Methods and compositions for decreasing T-cell activity
10. 7737257 - Connective tissue growth factor (CTGF-3)
11. 7709218 - Tumor necrosis factor receptors 6α and 6β
12. 7611846 - Diagnostic methods involving human growth factor huXAG-1
13. 7534428 - Antibodies to tumor necrosis factor receptors 6α and 6β
14. 7459531 - 50 Human secreted proteins
15. 7381800 - Antibodies to HBIMF63 polypeptide